A No-Carb Diet: An Overview of Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacterales

Epidemiology Carbapenem-resistant Enterobacterales (CRE) can generally be classified as carbapenemase-producing CRE and non–carbapenemase-producing (non-CP) CRE.

January 14, 2026 No Comments

Phase 3 Clinical Trial Reporting, Prospective Regulatory Filings to Watch For in 2026

This year will bring about the reporting of data for clinical trials, launch of studies,

January 13, 2026 No Comments

Invasive Fungal Disease in Transplantation: Prevention in a Shifting Landscape

For a patient recovering from a lifesaving transplant, an invasive fungal disease (IFD) can derail

January 13, 2026 No Comments

A new test reveals which antibiotics truly kill bacteria

Antibiotics are often judged by how well they slow or stop bacterial growth in laboratory

January 13, 2026 No Comments

Prospective Game Changer: Lenacapavir for HIV Preexposure Prophylaxis

In 2024, approximately 1.3 million people contracted HIV.1 Since the peak of 3.4 million new

January 12, 2026 No Comments

COVID-19: The Gaps in Science Communication

There are many long-lasting impacts that we have seen from the COVID-19 pandemic. Some of

January 11, 2026 No Comments

A room full of flu patients and no one got sick

This year’s flu season has been especially harsh, driven in part by the rapid spread

January 11, 2026 No Comments

Unlocking New Defenses: The Changing Landscape of Candida auris Management

Candida (Candidozyma) auris is a rapidly emerging global nosocomial pathogen with limited therapeutic options. Its

January 9, 2026 No Comments

What’s New in 2025: From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing (AST) held meetings

January 9, 2026 No Comments

A No-Carb Diet: An Overview of Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacterales

Phase 3 Clinical Trial Reporting, Prospective Regulatory Filings to Watch For in 2026

Invasive Fungal Disease in Transplantation: Prevention in a Shifting Landscape

A new test reveals which antibiotics truly kill bacteria

Prospective Game Changer: Lenacapavir for HIV Preexposure Prophylaxis

COVID-19: The Gaps in Science Communication

A room full of flu patients and no one got sick

Top Infectious Disease News Stories Week of January 3 – January 9

Unlocking New Defenses: The Changing Landscape of Candida auris Management

What’s New in 2025: From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

Schedule an Appointment

Quick Links

Patient Forms

Contact Us